The cyclooxygenase inhibitors indomethacin and Rofecoxib reduce regional cerebral blood flow evoked by somatosensory stimulation in rats

Experimental Biology and Medicine

Volumn 227, Issue 7, 2002, Pages 465-473

  Bakalova, Rumiana ^a,b   Matsuura, Tetsuia ^a   Kanno, Iwao ^a  

^a RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^b Inst for Structural Eng Materials   (Japan)

Author keywords

Cerebral blood flow; Hind paw stimulation; Indomethacin; Laser Doppler flowmetry; Rofecoxib (MK 0966); Somatosensory cortex

Indexed keywords

CHLORALOSE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; DRUG SELECTIVITY; ELECTROSTIMULATION; FOOT; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; RAT; SOMATOSENSORY CORTEX; SOMATOSENSORY STIMULATION;

ANIMALIA;

EID: 0036656148     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222700710     Document Type: Article

References (46)

1. Pickard JD. Role of prostaglandins and arachidonic acid derivatives in the coupling of cerebral blood flow to cerebral metabolism. J Cereb Blood Flow Metab 1:361-384, 1981.
2. Lipsky PE, Brooks P, Crofford LJ, DuBois R, Graham D, Simon LS, van de Putte LB, Abramson SB. Unresolved issues in the role of cyclooxygenase-2 in normal physiological processes and disease. Arch Intern Med 160(7):913-920, 2000.
3. O'Banion MK. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 13(1):45-82, 1999.
4. Yates SL, Levine L, Rosenberg P. Leukotriene and prostaglandin production in rat brain synaptosomes treated with phospholipase A2 neurotoxins and enzymes. Prostaglandins 39(4):425-438, 1990.
5. Kolko M, Bruhn T, Christensen T, Lazdunski M, Lambeau G, Bazan NG, Diemer NH. Secretory phospholipase A2 potentiates glutamate-induced rat striatal neuronal cell death in vivo. Neurosci Lett 274(3):167-170, 1999.
6. Naffah-Mazzacoratti MG, Bellfssimo MI, Cavalheiro EA. Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. Neurochem Int 27(6):461-466, 1995.
7. Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA, Sapirstein A. Reduced fertility and postischemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390:622-625, 1997.
8. Gaetani P, Marzatico F, Renault B, Fulle I, Lombardi D, Ferlenga P, Rodriguez y Baena R. High-dose methylprednisolone and 'ex vivo' release of eicosanoids after experimental subarachnoid haemorrhage. Neurol Res 12(2):111-116, 1990.
9. Melegos DN, Freedman MS, Diamandis EP. Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 54(1):463-474, 1997.
10. Dahlgren N, Rosen N, Nilsson B. The effect of indomethacin on the local cerebral blood flow increase, induced by somatosensory stimulation. Acta Physiot Scand 122:269-274, 1984.
11. Leftler CW, Mirro R, Pharris LJ, Shibata M. Permissive role of prostacyclin in cerebral vasodilation to hypercapnia in newborn pigs. Am J Physiol 267:H285-H291. 1994.
12. Heinert G, Nye PCG, Peterson DJ. Nitric oxide and prostaglandin pathways interact in the regulation of hypercapnic cerebral vasodilation. Acta Physiol Scand 166:183-193, 1999.
13. Siesjo BK, Rehncrona S, Smith D. Neuronal cell damage in the brain: possible involvement of oxidative mechanisms. Acta Physiol Scand Suppl 492:121-128, 1980.
14. Dahlgren N, Nilsson B, Sakabe T, Siesjo BK. The effect of indomethacin on cerebral blood flow and oxygen consumption in the rat at normal and increased carbon dioxide tension. Acta Physiol Scand 111:475-485, 1981.
15. Berkenbosch F. Macrophages and astroglial interactions in repair to brain injury. Ann N Y Acad Sci 650:186-190, 1992.
16. Golanov EV, Reis DJ. Nitric oxide and prostanoids participate in cerebral vasodilation elicited by electrical stimulation of the rostral ventrolateral medulla. J Cereb Blood Flow Metab 14:492-502, 1994.
17. Abdel-Halim MS, Lunden I, Cseh G, Anggard E. Prostaglandin profiles in nervous tissue and blood vessels of the brain of various animals. Prostaglandins 19:249-258, 1980.
18. Hawkey CJ. COX-2 inhibitors. Lancet 353:307-314, 1999.
19. Niwa K, Araki E, Morham SG, Ross E, Iadecola C. Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex. J Neurosci 20(2):763-770, 2000.
20. Nilsson GE, Tenland T, Oberg PA. Evaluation of a laser-Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biochem Eng 27:597-604, 1980.
21. Matsuura T, Fujita H, Seki C, Kashikura K, Kanno I. CBF change evoked by somatosensory activation measured by laser-Doppler flowmetry: independent evaluation of RBC velocity and RBC concentration. Jpn J Physiol 49:289-296, 1999.
22. Matsuura T, Fujita H, Kashikura K, Kanno I. Evoked local CBF induced by somatosensory stimulation is proportional to the baseline flow. Neurosci Res 38:341-348, 2000.
23. Detre JA, Ances BM, Takahashi K, Greenberg JH. Signal averaged laser-Doppler measurements of activation-flow coupling in the rat forepaw somatosensory cortex. Brain Res 796:91-98, 1998.
24. Ngai JA, Meno JR, Winn HR. Simultaneous measurements of pial arteriolar diameter and laser-Doppler flow during somatosensory stimulation. J Cereb Blood Flow Metab 15:124-127, 1995.
25. Niwa K, Haensel C, Ross E, Iadecola K. Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circulation Res 88:600-607, 2001.
26. Depre M, Ehrich E, DeLepeleire I. Demonstration of specific COX-2 inhibition by MK966 (Vioxx) in humans with supratherapeutic doses. Rheumatol Eur Suppl 1:27, 1998.
27. McCulloch J, Kelly PAT, Grome JJ, Pickard JD. Local cerebral circulatory and metabolic effects of indomethacin. Am J Physiol 243:H416-H423, 1982.
28. + enhances arachidonic acid release in MDCK-D1 cells. Am J Physiol 259(2 Pt 1):C224-C231, 1990.
29. 2 and cerebral circulation in newborn pigs: cyclic nucleotides and prostanoids in vascular regulation. Am J Physiol 266:H1494-H1501, 1994.
30. Busija DW, Heistad DD. Factors involved in the physiological regulation of the cerebral circulation. Rev Physiol Biochem Pharmacol 101:161-210, 1984.
31. Carola R, Harley JP, Noback ChR. Human Anatomy and Physiology. New York: McGraw-Hill, 1990.
32. Pourcyrous M, Busija DW, Shibata M, Bada HS, Korones SB, Leffler CW. Cerebrovascular responses to therapeutic dose of indomethacin in newborn pigs. Pediatr Res 45:582-587, 1999.
33. Nillson F, Bjerkman S, Rosen I, Messeter K, Nordstem CH. Cerebral vasoconstriction by indomethacin in intracranial hypertension: an experimental investigation in pigs. Anesthesiology 83(6):1283-1292, 1995.
34. 2 reactivity of cerebral arterioles is restored by vasodilator prostaglandin. Am J Physiol 266:H1332-H1338, 1994.
35. Parfenova H, Shibata M, Zuckerman S, Mirro R, Leffler CW. Cyclic nucleotides and cerebrovascular tone in newborn pigs. Am J Physiol 265:H1972-H1982, 1993.
36. Kanba S, Sasakawa N, Nakaki T, Kanba K-S, Yagi G, Kato R, Richelson E. Two possibly distinct prostaglandin E1 receptors in N1E-115 clone: one mediating inositol triphosphate formation, cyclic GMP formation, and intracellular calcium mobilization and the other mediating cyclic AMP formation. J Neurochem 57:2011-2015, 1991.
37. Jiang H, Colbran JL, Francis SH, Corbin JD. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 267(2):1015-1019, 1992.
38. Quintana A, Raczka E, Quintana MA. Effects of indomethacin and diclofenac on cerebral blood flow in hypercapnic conscious rats. Eur J Pharmacol 149:385-388, 1988.
39. Abdel-Halim MS, Sjoquist B, Anggard E. Inhibition of prostaglandin synthesis in rat brain. Acta Pharmacol Toxicol 43:266-271, 1978.
40. Shimokawa H, Flavahan NA, Lorentz RR, Vanhoutte PM. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary artery of the pig. Br J Pharmacol 95:1197-1203, 1988.
41. Stephenson AH, Sprague RS, Lonigro AJ. 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog. Am J Physiol 275(1 Pt 2):H100-H109, 1998.
42. Narumiya S. Prostanoid receptors and signal transduction. Prog Brain Res 113:231-241, 1996.
43. Howlett AC, Mukhopadhyay S, Shim JY, Welsh WJ. Signal transduction of eicosanoid CB1 receptor ligands. Life Sci 65(6-7):617-625, 1999.
44. Suzuki H, Ikezaki H, Hong D, Rubinstein I. PGH(2)-TxA(2)-receptor blockade restores vasoreactivity in a new rodent model of genetic hypertension. J Appl Physiol 88(6):1983-1988, 2000.
45. Nowack VH, Zeiller P. Steck K. Plasmaspiegel und Gewebskonzentrationen beim Kaninchen nach kutaner Applikation einer Indometacin-Lösung. Arzneim-Forsch Drug Res 37(4):432-434, 1987.
46. Jamali F, Sattari S. High performance liquid chromatographic determination of cyclooxygenase II inhibitor Rofecoxib in rat and human plasma. J Pharm Pharm Sci 3:312-317, 2000.